Crystallization of recombinant rat cathepsin B

Area of Science:

• Biochemistry
• Structural Biology
• Enzymology

Background:

• Cathepsin B is a key cysteine protease involved in various physiological and pathological processes.
• Understanding the three-dimensional structure of cathepsin B is crucial for developing targeted inhibitors.
• Glycosylation can influence protein structure, stability, and function.

Purpose of the Study:

• To obtain a high-resolution crystal structure of recombinant rat cathepsin B.
• To investigate the structural characteristics of a glycosylation-minus mutant of rat cathepsin B.
• To facilitate structure-based drug design for cathepsin B inhibitors.

Main Methods:

• Expression of a glycosylation-minus mutant of rat cathepsin B in yeast.
• Purification of the recombinant protein.
• Crystallization of the purified mutant protein.
• Collection of X-ray diffraction data.
• Determination of the crystal space group and unit cell dimensions.

Main Results:

• The glycosylation-minus mutant of rat cathepsin B was successfully purified and crystallized.
• The crystal belongs to the space group P2(1) with specific unit cell dimensions (a = 62.2 Å, b = 90.19 Å, c = 47.07 Å, β = 97.43°).
• The unit cell contains 4 molecules, with 2 molecules per asymmetric unit, indicating potential dimeric or pseudo-dimeric arrangements.

Conclusions:

• The crystallization of the glycosylation-minus rat cathepsin B mutant provides a foundation for structure determination.
• The collected X-ray diffraction data are suitable for solving the three-dimensional structure.
• Further structural analysis will elucidate the enzyme's active site and conformational states, aiding therapeutic development.